Compare Stocks → If you have $2,500 bucks… check this out (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CATHNASDAQ:PLWNASDAQ:PNQINASDAQ:PPH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATHGlobal X S&P 500 Catholic Values ETF$61.65+0.8%$62.03$49.45▼$63.77$813.78M1.0131,435 shs23,647 shsPLWInvesco Equal Weight 0-30 Years Treasury ETF$26.79+0.3%$27.67$27.35▼$31.11$609.09M0.04108,768 shs72,683 shsPNQIInvesco NASDAQ Internet ETF$39.01+2.0%$39.34$27.45▼$40.57$743.92M1.15139,733 shs42,872 shsPPHVanEck Pharmaceutical ETF$86.80+0.3%$88.69$74.05▼$91.16$498.23M0.72132,669 shs616,575 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATHGlobal X S&P 500 Catholic Values ETF-0.34%+1.06%-3.00%+3.26%+23.17%PLWInvesco Equal Weight 0-30 Years Treasury ETF-0.45%-0.89%-3.94%-4.32%-10.51%PNQIInvesco NASDAQ Internet ETF-1.38%-0.66%-4.55%+1.77%+42.05%PPHVanEck Pharmaceutical ETF+0.17%+1.94%-3.78%+1.92%+10.44%Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/AN/AN/APLWInvesco Equal Weight 0-30 Years Treasury ETFN/AN/AN/AN/AN/AN/AN/AN/APNQIInvesco NASDAQ Internet ETFN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATHGlobal X S&P 500 Catholic Values ETF0.00N/A$67.759.90% UpsidePLWInvesco Equal Weight 0-30 Years Treasury ETF0.00N/AN/AN/APNQIInvesco NASDAQ Internet ETF0.00N/A$43.7712.21% UpsidePPHVanEck Pharmaceutical ETF0.00N/A$95.469.98% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATHGlobal X S&P 500 Catholic Values ETFN/AN/AN/AN/AN/AN/APLWInvesco Equal Weight 0-30 Years Treasury ETFN/AN/AN/AN/AN/AN/APNQIInvesco NASDAQ Internet ETFN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATHGlobal X S&P 500 Catholic Values ETFN/AN/A25.18∞N/AN/AN/AN/AN/APLWInvesco Equal Weight 0-30 Years Treasury ETFN/AN/A0.00∞N/AN/AN/AN/AN/APNQIInvesco NASDAQ Internet ETFN/AN/A8.95∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A20.57∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATHGlobal X S&P 500 Catholic Values ETF$0.671.09%N/AN/AN/APLWInvesco Equal Weight 0-30 Years Treasury ETF$0.702.61%N/AN/A1 YearsPNQIInvesco NASDAQ Internet ETF$0.030.07%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.561.80%N/AN/AN/ALatest PNQI, PLW, CATH, and PPH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024PPHVanEck Pharmaceutical ETF$0.53284/1/20244/2/20244/5/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/APLWInvesco Equal Weight 0-30 Years Treasury ETFN/APNQIInvesco NASDAQ Internet ETFN/APPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipCATHGlobal X S&P 500 Catholic Values ETFN/APLWInvesco Equal Weight 0-30 Years Treasury ETFN/APNQIInvesco NASDAQ Internet ETFN/APPHVanEck Pharmaceutical ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCATHGlobal X S&P 500 Catholic Values ETF147,00013.20 millionN/AOptionablePLWInvesco Equal Weight 0-30 Years Treasury ETF147,00022.74 millionN/ANot OptionablePNQIInvesco NASDAQ Internet ETF147,00019.07 millionN/AOptionablePPHVanEck Pharmaceutical ETF147,0005.74 millionN/AOptionablePNQI, PLW, CATH, and PPH HeadlinesSourceHeadlinePPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returnsseekingalpha.com - April 23 at 7:30 AMCanada’s updated guidance on ESG-related investment fund disclosuretheglobeandmail.com - April 18 at 10:38 AMJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focuszacks.com - April 17 at 11:00 AMVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 3 at 8:35 AMVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328msn.com - April 1 at 2:26 PMShould You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com - March 8 at 7:21 AMThe Top 3 ETFs to Buy in March 2024investorplace.com - March 7 at 1:43 PM11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yieldsmarkets.businessinsider.com - February 28 at 3:40 PMNavigate to Success With These 4 Pharma Stocks to Buystocknews.com - February 28 at 1:01 PMThe 3 Hottest Healthcare ETFs to Buy in 2024investorplace.com - February 26 at 2:12 PMPPH VanEck Pharmaceutical ETFseekingalpha.com - February 21 at 8:39 PMHealthcare dealmakers see increased M&A, valuations in 2024: KPMGmsn.com - February 20 at 7:16 AMPharma ETF (PPH) Hit a 52-Week Highzacks.com - February 19 at 9:50 AMBig Pharma earnings season in spotlight amid positive sentimentmsn.com - January 28 at 1:06 PM5 ETF Zones Scaling New Highs at the Start of 2024finance.yahoo.com - January 8 at 1:13 PMPfizer in 2024: What to expect?msn.com - December 29 at 1:39 PMGilead in 2024: What to expect?msn.com - December 28 at 1:41 PMETFs to buy and sell as the GLP-1 craze boomscnbc.com - December 6 at 9:53 AM10 Best Performing Healthcare ETFs in 2023uk.finance.yahoo.com - November 14 at 4:43 PMPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your Portfoliomsn.com - November 6 at 1:27 PMPPH ETF Stock Price Historyinvesting.com - November 1 at 5:10 PMPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfoliomsn.com - October 29 at 7:35 AM3 Resilient Pharma Stocks to Buy This Weekstocknews.com - October 26 at 9:05 PMOzempic craze drives big flows into pharmaceutical, Danish fundsmsn.com - October 25 at 12:42 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsGlobal X S&P 500 Catholic Values ETFNASDAQ:CATHThe Global X S&P 500 Catholic Values ETF (CATH) is an exchange-traded fund that is based on the S&P 500 Catholic Values index. The fund tracks an index of US large-cap stocks selected from the S&P 500. The cap-weighted index omits companies from certain industries at odds with Catholic values. CATH was launched on Apr 18, 2016 and is managed by Global X.Invesco Equal Weight 0-30 Years Treasury ETFNASDAQ:PLWThe Invesco 1-30 Laddered Treasury ETF (PLW) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an index that invests in an equal-weighted 30-year ladder of US Treasury securities. PLW was launched on Oct 11, 2007 and is managed by Invesco.Invesco NASDAQ Internet ETFNASDAQ:PNQIThe Invesco NASDAQ Internet ETF (PNQI) is an exchange-traded fund that is based on the NASDAQ Internet index, a modified-market-cap-weighted index of Internet companies listed in the US. PNQI was launched on Jun 12, 2008 and is managed by Invesco.VanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.